Esperite (voorheen Cryo Save)« Terug naar discussie overzicht

1. DeZwarteRidder 5 augustus 2020 14:06

   auteur info

   •    DeZwarteRidder

     Lid sinds: 29 jun 2012

     Laatste bezoek: 21 nov 2024

   •    Aanbevelingen

     Ontvangen: 23265

     Gegeven: 10291

   •    Aantal posts: 100.723

   Company press releases
   Displaying 21 - 40 of 110 results
   Released Company Title Industry Topic
   01 Jul 2019
   07:17 CEST ESPERITE
   ESPERITE NV (ESP) AVEC CRYOSAVE CONFIRME LA SÉCURITÉ DE TOUS LES ÉCHANTILLONS STOCKÉS ET REMERCIE LES 260'000 FAMILLES POUR LEUR CONFIANCE.
   Biotechnology Alliances and agreements
   30 Jun 2019
   21:01 CEST ESPERITE
   ESPERITE N.V. (ESP) publishes its half-year report. Revenues, results and consolidated equity were impacted by adverse market conditions on the stem cell business.
   Biotechnology New
   28 Jun 2019
   23:51 CEST ESPERITE
   Esperite N.V.: Update to the market on the publication of the Annual Report 2018
   Biotechnology New
   25 Jun 2019
   22:59 CEST ESPERITE
   ESPERITE (ESP) announces termination of negotiations regarding proposed sale of stem cell banking business to PBKM
   Biotechnology Other subject
   14 Jun 2019
   08:54 CEST ESPERITE
   ESPERITE (ESP) negotiates 18-month extension for EUR 4,750,000 in unsecured convertible loan notes
   Biotechnology Other subject
   13 Jun 2019
   07:17 CEST ESPERITE
   ESPERITE (ESP) resumes negotiations regarding proposed sale of stem cell banking business to PBKM
   Biotechnology Other subject
   04 Jun 2019
   10:18 CEST ESPERITE
   Esperite NV (ESP) introduces Jouvene - Swiss Medicine Quintessence, the first combined offer of Stem Cell long term storage and highly accurate Whole Genome Sequencing for Consumer distribution.
   Biotechnology Other subject
   29 May 2019
   08:26 CEST ESPERITE
   ESPERITE (ESP) announces termination of MoU regarding proposed sale of stem cell banking business to PBKM due to lack of agreement on the terms of the sale
   Biotechnology Other subject
   19 May 2019
   22:54 CEST ESPERITE
   ESPERITE (ESP) announces listing measure by Euronext due to delay in publication of its 2018 annual report (as announced on 30 April 2019)
   Biotechnology Other subject
   13 May 2019
   07:17 CEST ESPERITE
   Esperite N.V. (ESP) : Update to the market on the publica-tion of the Annual Report 2018 and The Cell Factory cur-rent configuration.
   Biotechnology Other subject
   01 May 2019
   16:58 CEST ESPERITE
   Esperite N.V. (ESP) : Update to the market on the publication of the Annual Report 2018
   Biotechnology Other subject
   05 Apr 2019
   07:17 CEST ESPERITE
   ESPERITE (ESP) announces private placement of convertible loan notes to the European Select Growth Opportunities Fund
   Biotechnology Other subject
   27 Feb 2019
   07:17 CET ESPERITE
   Esperite N.V. (ESP) with The Cell Factory has confirmed a long-term effect of extracellular vesicle drug candidate CF-MEV-132 for the treatment of Bronchopulmonary Dysplasia.
   Biotechnology Other subject
   26 Feb 2019
   07:17 CET ESPERITE
   ESPERITE (ESP) announces private placement of convertible loan notes to the European Select Growth Opportunities Fund
   Biotechnology Other subject
   22 Feb 2019
   07:17 CET ESPERITE
   ESPERITE NV (ESP) AND PBKM (FAMICORD GROUP) SIGN EXCLUSIVE AGREEMENT REGARDING POTENTIAL ACQUISITION OF CRYO-SAVE’S FAMILY STEM CELL BANKING BUSINESS.
   Biotechnology Other subject
   10 Jan 2019
   07:17 CET ESPERITE
   ESPERITE (ESP) : European Select Growth Opportunities Fund subscribes to the 24th tranche of investment today
   Biotechnology Other subject
   30 Nov 2018
   07:17 CET ESPERITE
   ESPERITE (ESP) : European Select Growth Opportunities Fund subscribes to the 23rd tranche of investment today
   Biotechnology Other subject
   29 Nov 2018
   07:17 CET ESPERITE
   Esperite (ESP) with The Cell Factory, prepares to raise series A round of investments to continue its clinical program testing Extracellular Vesicles drug candidates.
   Biotechnology Other subject
   27 Nov 2018
   18:26 CET ESPERITE
   ESPERITE N.V. convenes Annual General Meeting of Shareholders
   Biotechnology Other subject
   23 Nov 2018
   23:35 CET ESPERITE
   ESPERITE (ESP): financial results for 2017 are published.
   Biotechnology Other subject
   
   
2. DeZwarteRidder 5 augustus 2020 14:07

   auteur info

   •    DeZwarteRidder

     Lid sinds: 29 jun 2012

     Laatste bezoek: 21 nov 2024

   •    Aanbevelingen

     Ontvangen: 23265

     Gegeven: 10291

   •    Aantal posts: 100.723

   Met nepnieuws bedoel ik nieuws wat bedoelt is om de aandeelhouders te misleiden.
3. DeZwarteRidder 5 augustus 2020 14:09

   auteur info

   •    DeZwarteRidder

     Lid sinds: 29 jun 2012

     Laatste bezoek: 21 nov 2024

   •    Aanbevelingen

     Ontvangen: 23265

     Gegeven: 10291

   •    Aantal posts: 100.723

   Company press releases
   Displaying 41 - 60 of 110 results
   Released Company Title Industry Topic
   19 Nov 2018
   15:35 CET ESPERITE
   ESPERITE (ESP) announces publication of its Annual Report 2017 before 24 November 2018
   Biotechnology Other subject
   09 Nov 2018
   07:17 CET ESPERITE
   ESPERITE (ESP) expects publication of Annual Report 2017 before 17 November 2018
   Biotechnology Other subject
   07 Nov 2018
   07:17 CET ESPERITE
   Esperite Group with The Cell Factory, expands its patent portfolio on extra-cellular vesicles biologic drugs in Canada.
   Biotechnology Other subject
   06 Nov 2018
   08:56 CET ESPERITE
   Esperite Group with The Cell Factory expands its Extracellular Vesicles product portfolio of anti-inflammatory drugs with a fourth indication : Bronchopulmonary Dysplasia.
   Biotechnology Other subject
   15 Oct 2018
   07:17 CEST ESPERITE
   ESPERITE (ESP) : European Select Growth Opportunities Fund subscribes to the 22nd tranche of investment today
   Biotechnology Other subject
   03 Oct 2018
   18:18 CEST ESPERITE
   Esperite N.V. (ESP): Sale by Esperite of stake in Cryo-Save South Africa cancelled
   Biotechnology Other subject
   13 Sep 2018
   07:17 CEST ESPERITE
   ESPERITE N.V. (ESP) WITH CRYOSAVE READY TO STORE MORE THAN A MILLION SAMPLES IN ITS NEW DESIGNED CRYOSTORAGE FACILITY IN GENEVA.
   Biotechnology Other subject
   31 Aug 2018
   07:17 CEST ESPERITE
   Esperite N.V. (ESP) : Update to the market on the publication of the Annual Report 2017.
   Biotechnology Other subject
   29 Aug 2018
   07:17 CEST ESPERITE
   ESPERITE (ESP) : European Select Growth Opportunities Fund subscribes to the 21st tranche of investment today
   Biotechnology Other subject
   15 Aug 2018
   07:17 CEST ESPERITE
   Esperite N.V. (ESP) : Update on the publication of the Annual Report 2017.
   Biotechnology Other subject
   18 Jul 2018
   08:26 CEST ESPERITE
   Esperite N.V. (ESP) : Additional delays needed on the publication of the Annual Report 2017
   Biotechnology Other subject
   02 Jul 2018
   07:17 CEST ESPERITE
   ESPERITE N.V. (ESP) SELLS ITS STAKE IN CRYOSAVE SOUTH AFRICA TO GO LIFE HEALTHCARE (GLI).
   Biotechnology Other subject
   28 Jun 2018
   07:17 CEST ESPERITE
   ESPERITE (ESP) : European Select Growth Opportunities Fund subscribes to the 20th tranche of investment today
   Biotechnology Other subject
   19 Jun 2018
   07:17 CEST ESPERITE
   Esperite N.V. secures external financing of up to EUR 5 million to support its commercial activity and development of innovative technologies
   Biotechnology Other subject
   18 Jun 2018
   22:24 CEST ESPERITE
   ESPERITE (ESP) further delays publication of Annual Report 2017.
   Biotechnology Other subject
   12 Jun 2018
   07:17 CEST ESPERITE
   European Select Growth Opportunities Fund subscribes to the 19th tranche of its investment today and has agreed to provide up to EUR 7.25 million in additional funding
   Biotechnology Other subject
   06 Jun 2018
   08:26 CEST ESPERITE
   ESPERITE NV (ESP) LAUNCHS NEW AGAATA Dx, DIAGNOSTIC SYSTEM WITH MACHINE LEARNING CAPABILITIES FOR GENETIC CLINICAL LABORATORIES.
   Biotechnology Other subject
   05 Jun 2018
   07:17 CEST ESPERITE
   ESPERITE (ESP) expects publication of Annual Report 2017 before 18 June 2018
   Biotechnology Other subject
   17 May 2018
   14:33 CEST ESPERITE
   Esperite NV (ESP) with The Cell Factory has signed the agreement with the PHARM CRO to start preparation for the first-in-man clinical trials in treatment of Crohn's disease.
   Biotechnology Other subject
   17 May 2018
   07:17 CEST ESPERITE
   ESPERITE (ESP) : L1 Capital subscribes to the 18th tranche of investment today
   Biotechnology Other subject
   
4. DeZwarteRidder 5 augustus 2020 14:10

   auteur info

   •    DeZwarteRidder

     Lid sinds: 29 jun 2012

     Laatste bezoek: 21 nov 2024

   •    Aanbevelingen

     Ontvangen: 23265

     Gegeven: 10291

   •    Aantal posts: 100.723

   Company press releases
   Displaying 61 - 80 of 110 results
   Released Company Title Industry Topic
   16 May 2018
   09:31 CEST ESPERITE
   ESPERITE NV (ESP) WITH CRYOSAVE TAKES OVER FULL CONTROL OF BUSINESS IN SOUTH AFRICA AND INTEND TO DISTRIBUTE ADVANCED SERVICES TO THE GROWING AFRICAN POPULATION
   Biotechnology Other subject
   03 May 2018
   11:36 CEST ESPERITE
   Esperite's (ESP) The Cell Factory received European funding to develop the 2nd generation EVs drug for treatment of Stroke
   Biotechnology Other subject
   30 Apr 2018
   12:55 CEST ESPERITE
   ESPERITE NV (ESP) delays publication of Annual Report 2017
   Biotechnology Other subject
   11 Apr 2018
   07:17 CEST ESPERITE
   ESPERITE (ESP): EUR 1,200,000 of new funding provided by European Select Growth Opportunities Fund until May 25, 2018.
   Biotechnology Other subject
   29 Mar 2018
   09:15 CEST ESPERITE
   Esperite (ESP), The Cell Factory presents pre-clinical results on the new products of the 2nd generation EV's drugs for treatment of inflammatory diseases
   Biotechnology Other subject
   02 Mar 2018
   07:17 CET ESPERITE
   ESPERITE (ESP) : L1 Capital subscribes to the 16th tranche of investment today
   Biotechnology Other subject
   16 Feb 2018
   07:17 CET ESPERITE
   ESPERITE (ESP): EUR 500,000 of new funding provided by European Select Growth Opportunities Fund until March 2, 2018.
   Biotechnology Other subject
   31 Jan 2018
   13:26 CET ESPERITE
   ESPERITE (ESP) and BGI Genomics (BGI) sign a strategic agreement to offer Whole Genome Sequencing on a large scale.
   Biotechnology Other subject
   31 Jan 2018
   07:17 CET ESPERITE
   ESPERITE (ESP) : L1 Capital subscribes to the 14th tranche of investment today
   Biotechnology Other subject
   16 Jan 2018
   07:17 CET ESPERITE
   ESPERITE (ESP) : L1 Capital subscribes to the 13th tranche of investment today
   Biotechnology Other subject
   10 Jan 2018
   15:07 CET ESPERITE
   ESPERITE (ESP) : transfers its laboratory activity to Geneva and consequently sells its Belgium loss making subsidiary and avoids EUR 4 millions of future cash out for charges and financial costs
   Biotechnology Other subject
   10 Jan 2018
   07:17 CET ESPERITE
   ESPERITE (ESP) : L1 Capital subscribes to the 12th tranche of investment today
   Biotechnology Other subject
   08 Jan 2018
   12:59 CET ESPERITE
   ESPERITE (ESP): CEO Frederic Amar converts a portion of his Loan Note into 1.5 million shares.
   Biotechnology Other subject
   05 Jan 2018
   10:56 CET ESPERITE
   ESPERITE (ESP): issues EUR 400'000 convertible note for additional financing provided by CEO Frederic Amar
   Biotechnology Other subject
   22 Dec 2017
   07:17 CET ESPERITE
   ESPERITE (ESP): EUR 1 million of new funding provided by European Select Growth Opportunities Fund until February 23, 2018
   Biotechnology Other subject
   17 Nov 2017
   08:19 CET ESPERITE
   ESPERITE N.V. (ESP) , Stabilisation before growth.
   Biotechnology Other subject
   09 Nov 2017
   08:54 CET ESPERITE
   ESPERITE (ESP) : L1 Capital invests for total EUR 500K today by subscribing to the Tenth tranche (EUR 250K) and shows confidence by investing additionally EUR 250K under the same conditions.
   Biotechnology Other subject
   09 Nov 2017
   07:17 CET ESPERITE
   ESPERITE (ESP) : L1 Capital subscribes to the Tenth tranche of investment today and shows confidence by investing additionally EUR 250K under the same conditions.
   Biotechnology Other subject
   30 Oct 2017
   07:17 CET ESPERITE
   ESPERITE (ESP) : L1 Capital subscribes to the Ninth tranche of investment today
   Biotechnology Other subject
   10 Oct 2017
   08:52 CEST ESPERITE
   ESPERITE (ESP) : EUR 1.1 million of new funding provided by L1 Capital to support Esperite's strategy, commercial activities and development of innovative technologies
   Biotechnology Other subject
   
5. DeZwarteRidder 5 augustus 2020 14:11

   auteur info

   •    DeZwarteRidder

     Lid sinds: 29 jun 2012

     Laatste bezoek: 21 nov 2024

   •    Aanbevelingen

     Ontvangen: 23265

     Gegeven: 10291

   •    Aantal posts: 100.723

   Company press releases
   Displaying 81 - 100 of 110 results
   Released Company Title Industry Topic
   10 Oct 2017
   07:17 CEST ESPERITE
   ESPERITE (ESP) : EUR 1.1 million of new funding provided by L1 Capital to support Esperite's strategy, commercial activities and development of innovative technologies
   Biotechnology Other subject
   02 Oct 2017
   07:17 CEST ESPERITE
   ESPERITE N.V. (ESP) publishes its half-year report. Revenues and results were unexpectedly impacted by pending legal actions.
   Biotechnology Other subject
   29 Sep 2017
   21:16 CEST ESPERITE
   ESPERITE N.V. (ESP) delays publication of 2017 Interim Financial Reporting
   Biotechnology Other subject
   31 Aug 2017
   07:17 CEST ESPERITE
   ESPERITE (ESP): L1 Capital subscribes to the Seventh tranche of investment today
   Biotechnology Other subject
   11 Aug 2017
   07:17 CEST ESPERITE
   ESPERITE (ESP): L1 Capital confirms its investment in Esperite and announces new funding for up to EUR 0.6 million before August 31, 2017
   Biotechnology Other subject
   05 Jul 2017
   07:17 CEST ESPERITE
   ESPERITE (ESP): L1 Capital subscribes to the fourth packed tranche of investment today
   Biotechnology Other subject
   15 Jun 2017
   07:17 CEST ESPERITE
   ESPERITE (ESP): L1 Capital subscribes to the third packed tranche of investment today
   Biotechnology Other subject
   01 Jun 2017
   07:17 CEST ESPERITE
   ESPERITE (ESP): L1 Capital subscribes to the second packed tranche today, ahead of schedule
   Biotechnology Other subject
   31 May 2017
   08:52 CEST ESPERITE
   ESPERITE (ESP) : L1 Capital confirms its investment in Esperite and announces new funding for up to EUR 1.1 million before July 12, 2017
   Biotechnology Other subject
   31 May 2017
   08:26 CEST ESPERITE
   ESPERITE (ESP) : L1 Capital confirms its investment in Esperite and announces new funding for up to EUR 1.1 million before July 12, 2017
   Biotechnology Other subject
   31 May 2017
   07:57 CEST ESPERITE
   ESPERITE (ESP) Q1 consolidated revenue higher compared to budget
   Biotechnology Other subject
   31 May 2017
   07:17 CEST ESPERITE
   ESPERITE (ESP) has concluded new agreements with its note holders
   Biotechnology Other subject
   23 May 2017
   15:44 CEST ESPERITE
   ESPERITE N.V. convenes Annual General Meeting of Shareholders
   Biotechnology Other subject
   23 May 2017
   07:17 CEST ESPERITE
   ESPERITE (ESP) financial results for 2016 published
   Biotechnology Other subject
   20 May 2017
   18:28 CEST ESPERITE
   Esperite further delays publication of 2016 Annual Report
   Biotechnology Other subject
   19 May 2017
   13:20 CEST ESPERITE
   Esperite (ESP) announces that Genoma SA filed appeal to the decision ruled by the Swiss Court
   Biotechnology Other subject
   15 May 2017
   10:17 CEST ESPERITE
   Esperite (ESP) - Esperite confirms the positive development of its current and future genetic activities and announces its intentions to claim 5.2 Million euro damages against Premaitha (NIPT)
   Biotechnology Other subject
   15 May 2017
   10:17 CEST ESPERITE
   Esperite (ESP) confirme le développement positif de ses activités génétiques et annonce son intention de réclamer 5,2 millions de dommages-intérêts à Premaitha (NIPT)
   Biotechnology Other subject
   15 May 2017
   07:17 CEST ESPERITE
   Esperite (ESP) confirme le développement positif de ses activités génétiques et annonce son intention de réclamer 5,2 millions de dommages-intérêts à Premaitha (NIPT)
   Biotechnology Other subject
   15 May 2017
   07:17 CEST ESPERITE
   Esperite (ESP) - Esperite confirms the positive development of its current and future genetic activities and announces its intentions to claim 5.2 Million euro damages against Premaitha (NIPT)
   Biotechnology Other subject
   
6. DeZwarteRidder 5 augustus 2020 14:11

   auteur info

   •    DeZwarteRidder

     Lid sinds: 29 jun 2012

     Laatste bezoek: 21 nov 2024

   •    Aanbevelingen

     Ontvangen: 23265

     Gegeven: 10291

   •    Aantal posts: 100.723

   Company press releases
   Displaying 101 - 110 of 110 results
   Released Company Title Industry Topic
   11 May 2017
   09:27 CEST ESPERITE
   Esperite (ESP): Patent granted in China for treatment of acute and chronic inflammatory and autoimmune diseases with EVs technology
   Biotechnology Other subject
   05 May 2017
   09:08 CEST ESPERITE
   Esperite (ESP), The Cell Factory demonstrate anti-inflammatory mode of action of CF-MEV-117 extracellular vesicle drug candidate for Epilepsy
   Biotechnology Other subject
   26 Apr 2017
   07:17 CEST ESPERITE
   ESPERITE delays publication of 2016 Annual Report
   Biotechnology Other subject
   25 Apr 2017
   07:17 CEST ESPERITE
   ESPERITE N.V. (ESP) WITH CRYOSAVE CONTRIBUTES TO TREATING A 9 YEAR OLD CHILD WITH THALASSEMIA MAJOR IN SWITZERLAND
   Biotechnology Other subject
   24 Apr 2017
   07:17 CEST ESPERITE
   ESPERITE's shareholders approved the external financing of up to EUR 13 million
   Biotechnology Other subject
   31 Mar 2017
   22:06 CEST ESPERITE
   CryoSave e Crioestaminal chegaram a um acordo para a armazenagem das células estaminais da Bioteca
   Biotechnology Other subject
   10 Mar 2017
   14:29 CET ESPERITE
   Esperite N.V. convenes Extraordinary General Meeting of Shareholders regarding external financing of up to EUR 13 million
   Biotechnology Other subject
   08 Mar 2017
   08:26 CET ESPERITE
   Esperite secures external financing of up to EUR 9 million to support its commercial activity and development of innovative technologies
   Biotechnology Other subject
   08 Mar 2017
   07:17 CET ESPERITE
   Esperite secures external financing of up to EUR 9 million to support its commercial activity and development of innovative technologies
   Biotechnology Other subject
   28 Feb 2017
   08:55 CET ESPERITE
   Esperite N.V.: Update on Financing
   Biotechnology Other subject
   
7. Amarillo 5 augustus 2020 15:13

   auteur info

   •    Amarillo

     Lid sinds: 22 jun 2020

     Laatste bezoek: 21 nov 2024

   •    Aanbevelingen

     Ontvangen: 143

     Gegeven: 29

   •    Aantal posts: 1.502

   Dat jij de moeite neemt om al die ouwe shit uit de put op te dreggenn
8. DeZwarteRidder 5 augustus 2020 15:32

   auteur info

   •    DeZwarteRidder

     Lid sinds: 29 jun 2012

     Laatste bezoek: 21 nov 2024

   •    Aanbevelingen

     Ontvangen: 23265

     Gegeven: 10291

   •    Aantal posts: 100.723

   quote:

   Amarillo schreef op 5 augustus 2020 15:13:

   Dat jij de moeite neemt om al die ouwe shit uit de put op te dreggenn
   

   Slimme mensen leren van het verleden.
   
   Iemand die deze berichten goed leest begrijpt dat hij wordt opgelicht.
   
   Ik wil newbies een eerlijke kans geven om hun geld al dan niet weg te gooien.
9. Amarillo 6 augustus 2020 07:34

   auteur info

   •    Amarillo

     Lid sinds: 22 jun 2020

     Laatste bezoek: 21 nov 2024

   •    Aanbevelingen

     Ontvangen: 143

     Gegeven: 29

   •    Aantal posts: 1.502

   Je weet wat ik gisteren zei he....in het verleden behaalde resultaten bieden geen garantie voor de toekomst
10. DeZwarteRidder 6 augustus 2020 07:42

    auteur info

    •    DeZwarteRidder

      Lid sinds: 29 jun 2012

      Laatste bezoek: 21 nov 2024

    •    Aanbevelingen

      Ontvangen: 23265

      Gegeven: 10291

    •    Aantal posts: 100.723

    quote:

    Amarillo schreef op 6 augustus 2020 07:34:

    Je weet wat ik gisteren zei he....in het verleden behaalde resultaten bieden geen garantie voor de toekomst
    

    Dat geldt natuurlijk ook voor jou met je opschepperij.
11. Amarillo 6 augustus 2020 08:45

    auteur info

    •    Amarillo

      Lid sinds: 22 jun 2020

      Laatste bezoek: 21 nov 2024

    •    Aanbevelingen

      Ontvangen: 143

      Gegeven: 29

    •    Aantal posts: 1.502

    We kunnen het ook omdraaien...waarom dwaal jij hier nog rond terwijl je niet 1 aandeel bezit?? Beetje overal tegenaan schoppen, ouwe koeien uit de sloot halen, ouwe berichten spammen....niks te doen zeker??
12. DeZwarteRidder 6 augustus 2020 08:59

    auteur info

    •    DeZwarteRidder

      Lid sinds: 29 jun 2012

      Laatste bezoek: 21 nov 2024

    •    Aanbevelingen

      Ontvangen: 23265

      Gegeven: 10291

    •    Aantal posts: 100.723

    quote:

    Amarillo schreef op 6 augustus 2020 08:45:

    We kunnen het ook omdraaien...waarom dwaal jij hier nog rond terwijl je niet 1 aandeel bezit?? Beetje overal tegenaan schoppen, ouwe koeien uit de sloot halen, ouwe berichten spammen....niks te doen zeker??
    

    Het is opvallend maar niet verbazingwekkend dat jij nooit ingaat op inhoudelijke zaken m.b.t. Esperite.
    
    Gelukkig kun je nog terecht in Benidorm, want daar kunnen ze altijd proppers gebruiken.
13. Amarillo 10 augustus 2020 16:47

    auteur info

    •    Amarillo

      Lid sinds: 22 jun 2020

      Laatste bezoek: 21 nov 2024

    •    Aanbevelingen

      Ontvangen: 143

      Gegeven: 29

    •    Aantal posts: 1.502

    Gelukkig vetrouwd ridder blind op dubieuze geert..
14. DeZwarteRidder 10 augustus 2020 16:52

    auteur info

    •    DeZwarteRidder

      Lid sinds: 29 jun 2012

      Laatste bezoek: 21 nov 2024

    •    Aanbevelingen

      Ontvangen: 23265

      Gegeven: 10291

    •    Aantal posts: 100.723

    quote:

    Amarillo schreef op 10 augustus 2020 16:47:

    Gelukkig vetrouwd ridder blind op dubieuze geert..
    

    Ik heb helemaal niks met Geert, zelfs geen abonnement.